Convalescent plasma for the treatment of patients with severe coronavirus disease 2019: A preliminary report.

Ali S Omrani Ahmed ZaqoutAnas BaiouJoanne DaghfalNaser ElkumRand A AlattarDana BakdachHatem AbusriwilAbdalrahman M MostafaBassem AlhaririNaseem AmbraMohamed KhatibAli M EldeebZeyd MerenkovZeinab FawziSaloua M HmissiAli A HssainPeter V CoyleHussam AlsoubMuna A AlmaslamaniAbdullatif Alkhal

Published in: Journal of medical virology (2020)

In severe COVID-19, convalescent plasma therapy was not associated with clinical benefits. Randomized trials are required to confirm our findings.

Keyphrases

coronavirus disease
early onset
sars cov
stem cells
combination therapy
bone marrow